{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:53:12Z","timestamp":1790848392157,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ygyno.2011.05.017","type":"journal-article","created":{"date-parts":[[2011,6,26]],"date-time":"2011-06-26T00:10:42Z","timestamp":1309047042000},"page":"663-668","source":"Crossref","is-referenced-by-count":18,"title":["Abnormal distribution of hDlg and PTEN in premalignant lesions and invasive cervical cancer"],"prefix":"10.1016","volume":"122","author":[{"given":"Elena\u00e9","family":"V\u00e1zquez-Ulloa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Lizano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Avil\u00e9s-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Alfaro-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Contreras-Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.05.017_bb0005","unstructured":"Cervical Cancer Incidence and Mortality Worldwide in 2008. Summary. Globocan 2008. Available from: http:\/\/globocan.iarc.fr\/factsheets\/cancers\/cervix.asp."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0010","unstructured":"Instituto Nacional de las Mujeres INMUJER. www.inmujeres.gob.mx."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0015","unstructured":"Cellular Classification of Cervical Cancer (Internet). National Cancer Institute. Available from: http:\/\/www.cancer.gov\/cancertopics\/pdq\/treatment\/cervical\/HealthProfessional\/page2."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0020","unstructured":"Human papillomaviruses and cancer: questions and answers. National Cancer Institute. http:\/\/www.cancer.gov\/cancertopics\/factsheet\/Risk\/HPV."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0025","first-page":"197","article-title":"Interactions of E6 and E7 oncoproteins with tumor suppressor gene products","volume":"12","author":"Mung\u00fcer","year":"1992","journal-title":"Cancer Surv."},{"issue":"7","key":"10.1016\/j.ygyno.2011.05.017_bb0030","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/JVI.70.7.4509-4516.1996","article-title":"High-risk papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation","volume":"70","author":"Li","year":"1996","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ygyno.2011.05.017_bb0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00705-007-0022-5","article-title":"Cellular binding partners of the human papillomavirus E6 protein","volume":"153","author":"Tungteakkun","year":"2008","journal-title":"Arch. Virol."},{"issue":"55","key":"10.1016\/j.ygyno.2011.05.017_bb0040","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1038\/onc.2008.351","article-title":"Human papillomaviruses, cervical cancer and cell polarity","volume":"27","author":"Thomas","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ygyno.2011.05.017_bb0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2010.07.046","article-title":"ERK5 pathway regulates the phosphorylation of tumor suppressor hDlg during mitosis","volume":"399","author":"I\u00f1esta-Vaquera","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.ygyno.2011.05.017_bb0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.onc.1203309","article-title":"The APC-hDlg complex negatively regulates cell cycle progression from the G0\/G1 to S phase","volume":"19","author":"Ishidate","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2011.05.017_bb0055","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1038\/sj.onc.1202920","article-title":"Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation","volume":"18","author":"Gardiol","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2011.05.017_bb0060","first-page":"35","article-title":"Threonine phosphorylation of the MMAC1\/PTEN PDZ binding domain both inhibits and stimulates PDZ binding","volume":"60","author":"Adey","year":"2000","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.ygyno.2011.05.017_bb0065","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.2004.02.141","article-title":"The biological relevance of the PTEN tumor suppressor pathway","volume":"22","author":"Sansal","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2011.05.017_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0","article-title":"Mutations of the human PTEN gene","volume":"16","author":"Bonneau","year":"2000","journal-title":"Human Mutation"},{"key":"10.1016\/j.ygyno.2011.05.017_bb0075","first-page":"3935","article-title":"Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies","volume":"57","author":"Tashiro","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0080","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/bcr322","article-title":"PTEN deficiency: a role in mammary carcinogenesis","volume":"3","author":"Petrocelli","year":"2001","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ijc.10962","article-title":"Frequent monoallelic deletion of PTEN and its reciprocal association with PIK3CA amplification in gastric carcinoma","volume":"104","author":"Byun","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2011.05.017_bb0090","first-page":"493","article-title":"Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy","volume":"18","author":"Harima","year":"2001","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2011.05.017_bb0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1525-1438.1998.98102.x","article-title":"Mutations in the PTEN tumor suppressor gene in cervical cancer","volume":"8","author":"Maxwell","year":"1998","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2011.05.017_bb0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virol.2008.09.040","article-title":"E6 variants of human papillomavirus 18 differentially mod\u00falate the protein kinase B\/phosphatidylinositol 3-kinase (AKT\/PI3K) signaling pathway","volume":"383","author":"Contreras","year":"2009","journal-title":"Virology"},{"issue":"23","key":"10.1016\/j.ygyno.2011.05.017_bb0105","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1242\/jcs.015230","article-title":"New insights into PTEN","volume":"120","author":"Tamguney","year":"2007","journal-title":"J. Cell Sci."},{"issue":"9","key":"10.1016\/j.ygyno.2011.05.017_bb0110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0968-0004(02)02166-7","article-title":"The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network","volume":"27","author":"Mayo","year":"2002","journal-title":"Trends Biochem. Sci."},{"issue":"13","key":"10.1016\/j.ygyno.2011.05.017_bb0115","doi-asserted-by":"crossref","first-page":"11116","DOI":"10.1074\/jbc.M108670200","article-title":"PTEN protects p53 from MdM2 and sensitizes cancer cells to chemotherapy","volume":"277","author":"Mayo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN Transcription by p53","volume":"8","author":"Stambolic","year":"2001","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.ygyno.2011.05.017_bb0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2559.2009.03468.x","article-title":"Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma","volume":"56","author":"Jang","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2011.05.017_bb0130","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0002-9440(10)65040-7","article-title":"Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors","volume":"156","author":"Gimm","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2011.05.017_bb0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ijc.10294","article-title":"Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma","volume":"99","author":"Whiteman","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2011.05.017_bb0140","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMcibr043143","article-title":"Loss of PTEN predicts resistance to treatment","volume":"351","author":"Pandolfi","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"Pt 3","key":"10.1016\/j.ygyno.2011.05.017_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1242\/jcs.022459","article-title":"The nuclear affairs of PTEN","volume":"121","author":"Planchon","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0150","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1525-1438.2006.00569.x","article-title":"Evaluation of PTEN expression in cervical adenocarcinoma by tissue microarray","volume":"16","author":"Tawkif","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2011.05.017_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and PI3-kinase pathway in cancer","volume":"4","author":"Chalhoub","year":"2009","journal-title":"Annu. Rev. Pathol."},{"issue":"9","key":"10.1016\/j.ygyno.2011.05.017_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012816","article-title":"Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity","volume":"5","author":"Fu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2011.05.017_bb0165","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/jcp.47.12.1073","article-title":"P53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium","volume":"47","author":"Jeffers","year":"1994","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0170","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/jcp.51.10.754","article-title":"Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer:correlation with p53 protein and high risk HPV infection","volume":"51","author":"Troncone","year":"1998","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2011.05.017_bb0175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00313029600169463","article-title":"Human papilloma virus and P53 overexpression in carcinomas of the uterine cervix, lower uterine segment and endometrium","volume":"28","author":"Hachisuga","year":"1996","journal-title":"Pathology"},{"issue":"1\u201312","key":"10.1016\/j.ygyno.2011.05.017_bb0180","first-page":"59","article-title":"Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo","volume":"11","author":"Anderson","year":"2006","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2011.05.017_bb0185","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2004.01.025","article-title":"Differential expression of human Dlg in cervical intraepithelial neoplasias","volume":"93","author":"Lin","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0190","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/JVI.01712-06","article-title":"E6AP-dependent degradation of DLG4\/PSD95 by High-risk human papillomavirus type 18 E6 protein","volume":"81","author":"Handa","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.20275","article-title":"Differential expression of the human homologue of drosophila discs large oncosuppressor in histologic samples from human papillomavirus-associated lesions as a marker for progression to malignancy","volume":"111","author":"Cavatorta","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2011.05.017_bb0200","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/carcin\/23.11.1791","article-title":"Changes in expression of the human homologue of the Drosophila discs large tumour suppressor protein in high-grade premalignant cervical neoplasias","volume":"23","author":"Watson","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2011.05.017_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2009.02.030","article-title":"The high-risk HPV E6 oncoprotein preferentially targets phosphorylated nuclear forms of hDlg","volume":"7","author":"Narayan","year":"2009","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.ygyno.2011.05.017_bb0210","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.yexcr.2007.05.017","article-title":"Changes in localization of human discs large (hDlg) during keratinocyte differentiation are associated with expression of alternatively spliced hDlg variants","volume":"313","author":"Roberts","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ygyno.2011.05.017_bb0215","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF00199349","article-title":"Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18","volume":"425","author":"Akasofu","year":"1995","journal-title":"Virchows Arch."},{"issue":"6","key":"10.1016\/j.ygyno.2011.05.017_bb0220","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/jcb.22100","article-title":"Post-transcriptional and post-translational regulation of PTEN by transforming growth factor-beta1","volume":"106","author":"Yang","year":"2009","journal-title":"J. Cell. Biochem."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811004070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811004070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T20:05:09Z","timestamp":1592683509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811004070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0090825811004070"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.05.017","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}